Development of a conditional mouse model for head and neck squamous cell carcinoma

Advances in Oto-Rhino-Laryngology

Volumn 62, Issue , 2005, Pages 1-11

  Bindels, E M J ^a   Van Den Brekel, M W M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEEDLE BIOPSY; NETHERLANDS; PATHOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE;

ANIMALS; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NETHERLANDS; SENSITIVITY AND SPECIFICITY;

EID: 16644392217     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (38)

1. Shklar G, Schwartz J, Grau D, Trickler DP, Wallace KD: Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg Oral Med Oral Pathol 1980;50:45-52.
2. Schwartz J, Gu X: Hamster oral cancer model; in Teicher BA (ed): Tumor Models in Cancer Research. Totowa, Human Press, 2002, pp 141-171.
3. Giminez Conti IB, Bianchi AB, Stockman SL, Conti CJ, Slaga TJ: Activating mutations of the Ha-ras in chemically induced tumors of the hamster cheek pouch. Mol Carcinog 1992;5:259-263.
4. Yuan B, Heniford BW, Ackermann BM, Hawkins BL, Hendler FJ: Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinoma and loss of heterozygosity occur without additional exposure. Cancer Res 1994;54:5310-5317.
5. Tang X-H, Knudson B, Bemis D, Tickoo S, Gudas LJ: Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 2004;10:301-313.
6. Hawkins BL, Heniford B, Ackermann D, Leonberger M, Martinez SA, Hendler FJ: 4NQO carcinogenesis: A mouse model of oral cavity squamous cell carcinoma. Head Neck 1994;16:424-432.
7. Culp SJ, Gaylor DW, Sheldon WG, Goldstein LS, Beland FA: A comparison of tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis 1998;7:1317-1322.
8. von Pressentin MDM, Kosinska W, Guttenplan JB: Mutagenesis induced by oral carcinogens in LacZ mouse (Muta™Mouse) and other oral tissues. Carcinogenesis 1999;20:2167-2170.
9. Ide F, Kitada M, Sakashita H, Kusama K, Tanaka K, Ishikawa T: p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Am J Pathol 2003;163:1729-1733.
10. Dinesman A, Haughey B, Gates GA, Aufdermorte T, Von Hoff DD: Development of a new in vivo model for head and neck cancer. Otolaryngol Head Neck Surg 1990;103:766-774.
11. Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ: An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 2002;8:293-298.
12. Jonkers J, Berns AB: Conditional mouse models of sporadic cancer. Nat Rev Cancer 2002;2:251-265.
13. Lewandoski M: Conditional control of gene expression in the mouse. Nat Genet 2001;2:743-755.
14. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A: Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001;29:418-425.
15. Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A: Induction of small cell lung cancer by somatic inactivation of both Trp53 and RB1 in a conditional mouse model. Cancer Cell 2003;4:181-189.
16. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, et al: Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003;4:209-221.
17. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437-450.
18. Ryding ADS, Sharp MGF, Mullins JJ: Conditional transgenic technologies. J Endocrinol 2001;171:1-14.
19. Gossen M, Bujard H: Studying gene function in eukaryotes by conditional gene inactivation. Annu Rev Genet 2002:36:163-173.
20. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lübbert H, Bujard H: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996;93:10933-10938.
21. Urlinger S, Baron U, Thellman M, Hasan MT, Bujard H, Hillen W: Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000;97:7963-7968.
22. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, et al: Essential role for oncogenic Ras in tumour maintenance. Nature 1999;400:468-472.
23. Nagy A: Cre recombinase: The universal reagent for genome tailoring. Genesis 2000;26:99-109.
24. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, et al: Growth inhibition and DNA damage by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 2001;98:9209-9214.
25. Silver DP, Livingston DM: Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 2001;8:233-243.
26. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR: Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 2000;97:13702-13707.
27. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP: Mammalian genomes contain active recombinase recognition sites. Gene 2000;244:47-54.
28. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM: Delivery of the Cre recombinase by a self-deleting lentiviral vector: Efficient gene targeting in vivo. Proc Natl Acad Sci USA 2001;98:11450-11455.
29. Forastiere A, Koch W, Trotti A, Sidransky D: Head and neck cancer. N Engl J Med 2001;345:1890-1900.
30. Wang X, Zinkel S, Polonsky K, Fuchs E: Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy. Proc Natl Acad Sci USA 1997;94:219-226.
31. Opitz OG, Harada H, Suliman Y, Rhoades B, Sharpless NE, Kent R, et al: A mouse model of human oral-esophageal cancer. J Clin Invest 2002;110:761-769.
32. Vooijs M, Jonkers J, Berns A: A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep 2001;2:292-297.
33. Soriano P: Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999;21:70-71.
34. T2 recombinases. Nucleic Acids Res 1999;27:4324-4327.
35. Hodgson G, Hagar JH, Volik S, Hariono S, Wernick M, Moore D, et al: Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 2001;29:459-464.
36. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, et al: Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 1996;14:312-315.
37. Weissleder R: Scaling down imaging: Molecular mapping of cancer in mice. Nat Rev Cancer 2002;2:1-8.
38. Lyons SK, Meuwissen R, Krimpenfort P, Berns A: The generation of a conditional reporter that enables bioluminescence imaging of Cre/loxP-dependent tumorigenesis in mice. Cancer Res 2003;63:7042-7046.